Cubist Systematic Strategies’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-168,252
| Closed | -$1.51M | – | 1469 |
|
|
2024
Q4 | $1.51M | Buy |
168,252
+147,843
| +724% | +$1.33M | 0.01% | 685 |
|
|
2024
Q3 | $150K | Buy |
+20,409
| New | +$150K | ﹤0.01% | 1189 |
|
|
2024
Q1 | – | Sell |
-88,622
| Closed | -$797K | – | 2223 |
|
|
2023
Q4 | $797K | Buy |
+88,622
| New | +$797K | 0.01% | 1206 |
|
|
2023
Q3 | – | Sell |
-25,038
| Closed | -$242K | – | 1987 |
|
|
2023
Q2 | $242K | Sell |
25,038
-245,986
| -91% | -$2.38M | ﹤0.01% | 1612 |
|
|
2023
Q1 | $2.97M | Buy |
271,024
+143,375
| +112% | +$1.57M | 0.02% | 896 |
|
|
2022
Q4 | $551K | Sell |
127,649
-58,330
| -31% | -$252K | ﹤0.01% | 2133 |
|
|
2022
Q3 | $1.4M | Buy |
+185,979
| New | +$1.4M | 0.01% | 1833 |
|
|
2022
Q2 | – | Sell |
-274,374
| Closed | -$3.4M | – | 3815 |
|
|
2022
Q1 | $3.4M | Buy |
+274,374
| New | +$3.4M | 0.03% | 1044 |
|
|
2021
Q2 | – | Sell |
-3,889
| Closed | -$50K | – | 2915 |
|
|
2021
Q1 | $50K | Buy |
3,889
+2,033
| +110% | +$26.1K | ﹤0.01% | 2734 |
|
|
2020
Q4 | $26K | Buy |
1,856
+1,411
| +317% | +$19.8K | ﹤0.01% | 2494 |
|
|
2020
Q3 | $7K | Sell |
445
-25,306
| -98% | -$398K | ﹤0.01% | 2441 |
|
|
2020
Q2 | $418K | Sell |
25,751
-8,636
| -25% | -$140K | 0.01% | 1684 |
|
|
2020
Q1 | $499K | Buy |
34,387
+31,080
| +940% | +$451K | 0.01% | 1261 |
|
|
2019
Q4 | $67K | Sell |
3,307
-2,465
| -43% | -$49.9K | ﹤0.01% | 2255 |
|
|
2019
Q3 | $31K | Buy |
5,772
+5,372
| +1,343% | +$28.9K | ﹤0.01% | 2092 |
|
|
2019
Q2 | $3K | Sell |
400
-27,700
| -99% | -$208K | ﹤0.01% | 2419 |
|
|
2019
Q1 | $183K | Buy |
28,100
+8,000
| +40% | +$52.1K | 0.01% | 1830 |
|
|
2018
Q4 | $137K | Buy |
+20,100
| New | +$137K | 0.01% | 1673 |
|
|
2018
Q1 | – | Sell |
-3,472
| Closed | -$16K | – | 1829 |
|
|
2017
Q4 | $16K | Buy |
+3,472
| New | +$16K | ﹤0.01% | 1845 |
|